Pfizer Inc.

In News

三生製藥(01530.HK)向輝瑞(PFE.US)授予雙特異性抗體產品獨家許可涉資60.5億美元 - AASTOCKS.com

AASTOCKS.com - May 19, 2025

輝瑞口服減重藥傳肝損風險研發計畫急踩煞車 - AASTOCKS.com

AASTOCKS.com - Apr 14, 2025

中國據報正與全球企業領袖聯繫或安排與習近平會面 | Anue鉅亨 - A股港股 - 鉅亨網

鉅亨網 - Mar 17, 2025

Citi Maintains a Hold Rating on Pfizer (PFE) Amidst Pricing Policy Headwinds - Yahoo Finance

Yahoo Finance - May 21, 2025

Pfizer 在 AWS re:Invent 2023 - Amazon Web Services (AWS)

Amazon Web Services (AWS) - Feb 15, 2024

輝瑞發佈ARCHER 1050 亞洲亞組分析的正面結果 - 美通社

美通社 - Nov 28, 2019

Structure Therapeutics股價因輝瑞退出肥胖藥物研發而上漲 - Investing.com 香港

Investing.com 香港 - Apr 15, 2025

全球疫苗分配不公大廠助長人權危機 - 國際特赦組織台灣分會

國際特赦組織台灣分會 - Feb 21, 2022

Pfizer Taiwan recalls anti-smoking drugs over nitrosamine concerns|English News - 僑務電子報

僑務電子報 - Jul 04, 2021

擴展亞洲業務BioNTech相中新加坡設廠- 新聞 - rti.org.tw

rti.org.tw - Nov 14, 2022

香港居民接種新冠疫苗可抽百萬美元住宅 - 华尔街日报中文网

华尔街日报中文网 - Jun 08, 2021

一生催生三種疫苗！前東德女兒出逃，成輝瑞BNT新冠疫苗幕後操盤手｜疫苗女王3 - 未來城市＠天下

未來城市＠天下 - Sep 20, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.